Literature DB >> 22850066

Testing clonality of three and more tumors using their loss of heterozygosity profiles.

Irina Ostrovnaya1.   

Abstract

Cancer patients often develop multiple malignancies that may be either metastatic spread of a previous cancer (clonal tumors) or new primary cancers (independent tumors). If diagnosis cannot be easily made on the basis of the pathology review, the patterns of somatic mutations in the tumors can be compared. Previously we have developed statistical methods for testing clonality of two tumors using their loss of heterozygosity (LOH) profiles at several candidate markers. These methods can be applied to all possible pairs of tumors when multiple tumors are analyzed, but this strategy can lead to inconsistent results and loss of statistical power. In this work we will extend clonality tests to three and more malignancies from the same patient. A non-parametric test can be performed using any possible subset of tumors, with the subsequent adjustment for multiple testing. A parametric likelihood model is developed for 3 or 4 tumors, and it can be used to estimate the phylogenetic tree of tumors. The proposed tests are more powerful than combination of all possible pairwise tests.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850066      PMCID: PMC4097189          DOI: 10.1515/1544-6115.1757

Source DB:  PubMed          Journal:  Stat Appl Genet Mol Biol        ISSN: 1544-6115


  16 in total

1.  Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.

Authors:  M Hampl; J A Hampl; G Reiss; G Schackert; H D Saeger; H K Schackert
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

2.  Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.

Authors:  Julie A Irving; Lluis Catasús; Alberto Gallardo; Elena Bussaglia; Marisa Romero; Xavier Matias-Guiu; Jaime Prat
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

3.  Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis.

Authors:  Eric Letouzé; Yves Allory; Marc A Bollet; François Radvanyi; Frédéric Guyon
Journal:  Genome Biol       Date:  2010-07-22       Impact factor: 13.583

4.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

5.  Evidence for common clonal origin of multifocal lung cancers.

Authors:  Xiaoyan Wang; Mingsheng Wang; Gregory T MacLennan; Fadi W Abdul-Karim; John N Eble; Timothy D Jones; Felix Olobatuyi; Rosana Eisenberg; Oscar W Cummings; Shaobo Zhang; Antonio Lopez-Beltran; Rodolfo Montironi; Suqin Zheng; Haiqun Lin; Darrell D Davidson; Liang Cheng
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

6.  Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.

Authors:  Patrick L Wagner; Naoki Kitabayashi; Yao-Tseng Chen; Sandra J Shin
Journal:  Am J Clin Pathol       Date:  2009-12       Impact factor: 2.493

7.  Molecular analysis of multifocal papillary thyroid carcinoma.

Authors:  Xiaoqi Lin; Sydney D Finkelstein; Bing Zhu; Jan F Silverman
Journal:  J Mol Endocrinol       Date:  2008-07-15       Impact factor: 5.098

8.  The clonal evolution of metastases from primary serous epithelial ovarian cancers.

Authors:  Lalarukh Khalique; Ayse Ayhan; John C Whittaker; Naveena Singh; Ian J Jacobs; Simon A Gayther; Susan J Ramus
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

9.  Inferring progression models for CGH data.

Authors:  Jun Liu; Nirmalya Bandyopadhyay; Sanjay Ranka; M Baudis; Tamer Kahveci
Journal:  Bioinformatics       Date:  2009-06-15       Impact factor: 6.937

10.  Recurrent and multiple bladder tumors show conserved expression profiles.

Authors:  David Lindgren; Sigurdur Gudjonsson; Kowan Ja Jee; Fredrik Liedberg; Sonja Aits; Anna Andersson; Gunilla Chebil; Ake Borg; Sakari Knuutila; Thoas Fioretos; Wiking Månsson; Mattias Höglund
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.